Company page

Nunzia Pharmaceutical Corporation

Nunzia Pharmaceutical Corporation, trading under the ticker NUNZ, operates in the American market with a market capitalization of approximately $43.45 million. The company focuses on developing pharmaceutical products and solutions. As a public entity, Nunzia is committed to advancing healthcare through innovative therapies.